{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:00Z","timestamp":1792611660711,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.contraception.2015.12.007","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T05:15:14Z","timestamp":1450415714000},"page":"303-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake"],"prefix":"10.1016","volume":"93","author":[{"given":"Ingrid J.M.","family":"Duijkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Heger-Mahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Drouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Skouby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2015.12.007_bb0005","series-title":"Medical eligibility criteria for contraceptive use: a WHO family planning cornerstone","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.contraception.2015.12.007_bb0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.12.007_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13625189909064007","article-title":"Oral progestogen-only contraceptives and cardiovascular risk: results from the transnational study on oral contraceptives and the health of young women","volume":"4","author":"Heinemann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2015.12.007_bb0020","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)04394-9","article-title":"Risk of idiopathic venous thromboembolism in users of progestogens alone","volume":"354","author":"Vasilakis","year":"1999","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2015.12.007_bb0025","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/0010-7824(94)90113-9","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.12.007_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0010-7824(80)90142-0","article-title":"Hormonal effects of the 300\u03bcg norethisterone (NET) minipill. 1. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration","volume":"21","author":"Landgren","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.12.007_bb0035","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/14.4.982","article-title":"A comparison of the inhibition of ovulation achieved by desogestrel 75\u03bcg and levonorgestrel 30\u03bcg daily","volume":"14","author":"Rice","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2015.12.007_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2004.07.016","article-title":"Maintenance of ovulation inhibition with the 75-\u03bcg desogestrel-only contraceptive pill (cerazette\u00ae) after scheduled 12-h delays in tablet intake","volume":"71","author":"Korver","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.12.007_bb0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2015.12.007_bb0050","first-page":"1","article-title":"A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24\/4 regimen","author":"Duijkers","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2015.12.007_bb0055","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1093\/humrep\/deh494","article-title":"Follicular growth during contraceptive pill or vaginal ring treatment depends on the day of ovulation in the pretreatment cycle","volume":"19","author":"Duijkers","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2015.12.007_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/acta.0.0940089","article-title":"Hormonal profile of the cycle in 68 normally menstruating women","volume":"94","author":"Landgren","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.contraception.2015.12.007_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1471-0528.1995.tb11396.x","article-title":"The combined oral contraceptive pill: what advice should we give when tablets are missed?","volume":"102","author":"Korver","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2015.12.007_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1783\/147118908786000451","article-title":"Ovulation incidence with oral contraceptives:a literature review","volume":"34","author":"Milsom","year":"2008","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2015.12.007_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2307\/2991665","article-title":"Compliance, counselling and satisfaction with oral contraceptives: a prospective evaluation","volume":"30","author":"Rosenberg","year":"1998","journal-title":"Fam Plan Perspect"},{"key":"10.1016\/j.contraception.2015.12.007_bb0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/ejc.7.3.155.161","article-title":"Oral contraception: patterns of non-compliance. The coraliance study","volume":"7","author":"Aubeny","year":"2002","journal-title":"Eur J Contrac Reprod Health Care"},{"key":"10.1016\/j.contraception.2015.12.007_bb0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2307\/2136191","article-title":"Measuring compliance among oral contraceptive users","volume":"28","author":"Potter","year":"1996","journal-title":"Fam Plan Perspect"},{"key":"10.1016\/j.contraception.2015.12.007_bb0090","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/AOG.0b013e3181eb6b0f","article-title":"Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial","volume":"116","author":"Hou","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.12.007_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008452.pub3","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"4","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415300226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415300226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T17:43:05Z","timestamp":1567446185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415300226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0010782415300226"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.12.007","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}